1. Ahlemeyer B, Bauerbach E, Plath M, Steuber M, Heers C, Tegtmeier F, Krieglstein J. Retinoic acid reduces apoptosis and oxidative stress by preservation of SOD protein level. Free Radic Biol Med. 2001. 30:1067–1077.
Article
2. Arruda VR, Salles TS, Costa FF, Saad ST. Glutathione peroxidase, reduced glutathione, superoxide dismutase and catalse in red cells of patients with hairy cell leukemia. Neoplasia. 1996. 43:99–102.
3. Bai J, Rodriguez AM, Melendez JA, Cederbaum AI. Overexpression of catalase in cytosolic or mitochondrial compartment protects HepG2 cells against oxidative injury. J Biol Chem. 1999. 274:26217–26224.
Article
4. Brodowicz T, Wiltschke C, Kandioler-Eckersberger D, Grunt TW, Rudas M, Schneider SM, Hejna M, Budinsky A, Zielinski CC. Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-alpha and retinoids. Br J Cancer. 1999. 80:1350–1358.
Article
5. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 1996. 10:940–954.
Article
6. Conte da Frota ML Jr, Comes da Silva E, Behr GA, Roberto de Oliveira M, Dal Pizzol F, Klamt F, Moreira JC. All trans retinoic acid induces free radical generation and modulate antioxidant enzyme activities in rat sertoli cells. Mol Cell Biochem. 2006. 285:173–179.
Article
7. Dietze EC, Caldwell LE, Marcom K, Collins SJ, Yee L, Swisshelm K, Hobbs KB, Bean GR, Seewaldt VL. Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300. Microsc Res Tech. 2002. 59:23–40.
Article
8. Dimberg A, Oberg F. Retinoic acid-induced cell cycle arrest of human myeloid cell lines. Leuk Lymphoma. 2003. 44:1641–1650.
Article
9. Drisko JA, Chapman J, Hunter VJ. The use of antioxidant therapies during chemotherapy. Gynecol Oncol. 2003. 88:434–439.
Article
10. Freemantle SJ, Spinella MJ, Dmitrovsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene. 2003. 22:7305–7315.
Article
11. Gallagher RE. Retinoic acid resistance in acute promyelocytic leukemia. Leukemia. 2002. 16:1940–1958.
Article
12. Gronemeyer H, Miturski R. Molecular mechanisms of retinoid action. Cell Mol Biol Lett. 2001. 6:3–52.
13. Hara M, Suzuki S, Mori J, Yamashita K, Kumagai M, Sakuma T, Kakizawa T, Takeda T, Miyamoto T, Ichikawa K, Hashizume K. Thyroid hormone regulation of apoptosis induced by retinoic acid in promyeloleukemic HL-60 cells: studies with retinoic acid receptor-specific and retinoid x receptor-specific ligands. Thyroid. 2000. 10:1023–1034.
Article
14. Hayashi K, Yokozaki H, Naka K, Yasui W, Lotan R, Tahara E. Overexpression of retinoic acid receptor beta induces growth arrest and apoptosis in oral cancer cell lines. Jpn J Cancer Res. 2001. 92:42–50.
Article
15. Hengartner MO. The biochemistry of apoptosis (review). Nature. 2000. 407:770–776.
16. Kuida K. Caspase-9. Int J Biochem Cell Biol. 2000. 32:121–124.
Article
17. Kuypers FA, Lewis RA, Hua M, Schott MA, Discher D, Ernst JD, Lubin BH. Detection of altered membrane phospholipids asymmetry in subpopulations of juman red blood cells using fluorescently labeled annexin V. Blood. 1996. 87:1179–1187.
Article
18. Manor D, Shmidt EN, Budhu A, Flesken-Nikitin A, Zgola M, Page R, Nikitin AY, Noy N. Mammary carcinoma suppressionby cellular retinoic acid binding protein-II. Cancer Res. 2003. 63:4426–4433.
19. Marill J, Idres N, Capron CC, Nguyen E, Chabot GG. Retinoic acid metabolism and mechanism of action: a review. Curr Drug Metab. 2003. 4:1–10.
Article
20. Melino G, Thiele CJ, Knight RA, Piacentini M. Retinoids and the control of growth/death decisions in human neuroblastoma cell lines. J Neurooncol. 1997. 31:65–83.
21. Nagase M, Alam MM, Tsushima A, Yoshizawa T, Sakato N. Apoptosis induction by T-2 toxin: activation of caspase-9, caspase-3 and DFF-40/CAD through cytosolic release of cytochrome C in HL-60 cells. Biosci Biotechnol Biochem. 2001. 65:1741–1747.
Article
22. Nagpal S, Chandraratna RA. Recent developments in receptor-selective retinoids. Curr Pharm Des. 2000. 6:919–931.
Article
23. Napoli JL. Retinoic acid biosynthesis and metabolism. FASEB J. 1996. 10:993–1001.
Article
24. Nelson AM, Gilliland KL, Cong Z, Thiboutot DM. 13-cis retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. J Invest Dermatol. 2006. 126:2178–2189.
Article
25. Nordberg J, Arner ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med. 2001. 31:1287–1312.
Article
26. Ott DB, Lachance PA. Retinoic acid-a review. Am J Clin Nutr. 1979. 32:2522–2531.
Article
27. Ott M, Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis. 2007. 12:913–922.
Article
28. Paik J, Blaner WS, Sommer KM, Moe R, Swisshlem K. Retinoids, retinoic acid receptors, and breast cancer. Cancer Invest. 2003. 21:304–312.
Article
29. Pepper C, Ali K, Thomas A, Hoy T, Fegan C, Chowdary P, Kell J, Bentley P. Retinoid-induced apoptosis in B-cell chronic lymphocytic leukaemia cells is mediated through caspase-3 activation and is independent of p53, the retinoic acid receptor, and differentiation. Eur J Haematol. 2002. 69:227–235.
Article
30. Pettersson F, Dalgleish AG, Bissonnette RP, Colston KW. Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/Bax. Br J Cancer. 2002. 87:555–561.
Article
31. Pigault C, Follenius-Wund A, Schmutz M, Freyssinet JM, Brisson A. Formation of two-dimensional arrays of annexin V on phosphatidylserine-containing liposomes. J Mol Biol. 1994. 236:199–208.
Article
32. Prakash P, Russell RM, Krinsky NI. In vitro inhibition of proliferation of estrogen-dependent and estrogen independent human breast cancer cells treated with carotenoids or retinoids. J Nutr. 2001. 131:1574–1580.
Article
33. Ralhan R, Kaur J. Retinoids as chemopreventive agents. J Biol Regul Homeost Agents. 2003. 17:66–91.
34. Raloff J. Antioxidants may help cancers thrive. Science News. 2000. 157:5.
35. Rishi AK, Zhang L, Boyanapalli M, Wali A, Mohammad RM, Yu Y, Fontana JA, Hatfield JS, Dawson MI, Majumdar AP, Reichert U. Identification and characterization of a cell cycle and apoptosis regulatory protein-1 as a novel mediator of apoptosis signaling by retinoid CD437. J Biol Chem. 2003. 278:33422–33435.
Article
36. Sato Y, Meller R, Yang T, Taki W, Simon RP. Stereo-selective neuroprotection against stroke with vitamin A derivatives. Brain Res. 2008. 1241:188–192.
Article
37. Seewaldt VL, Johnson BS, Parker MB, Collins SJ, Swisshelm K. Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ. 1995. 6:1077–1088.
38. Smith MA, Parkinson DR, Cheson BD, Friedman MA. Retinoids in cancer therapy. J Clin Oncol. 1992. 10:839–864.
Article
39. Soprano DR, Qin P, Soprano KJ. Retinoic acid receptors and cancers. Annu Rev Nutr. 2004. 24:201–221.
Article
40. Stennicke HR, Salvesen GS. Caspase assays. Methods Enzymol. 2000. 322:91–100.
Article
41. Sutherland MW, Learmonth BA. The tetrazolium dyes MTS and XTT provide new quantitative assays for superoxide and superoxide dismutase. Free Radic Res. 1997. 27:283–289.
Article
42. Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, Yodoi J. Redox control of cell death. Antioxi Redox Signal. 2002. 4:405–414.
Article
43. Villa P, Kaufmann SH, Earnshaw WC. Caspase and caspase inhibitors. Trends Biochem Sci. 1997. 22:388–393.
44. Windhorst DB, Nigra T. General clinical toxicology of oral retinoids. J Am Acad Dermatol. 1982. 6:675–682.
Article
45. Xu Q, Konta T, Kitamura M. Retinoic acid regulation of mesangial cell apoptosis. Exp Nephrol. 2002. 10:171–175.
Article
46. Xu XC, Liu X, Tahara E, Lippman SM, Lotan R. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res. 1999. 59:2477–2483.